{"organizations": [], "uuid": "0a8d5c9660e2b966d167772be40cdd56eb028264", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-akcea-completes-enrollment-in-phas/brief-akcea-completes-enrollment-in-phase-2b-study-of-akcea-apo-lrx-idUSFWN1PX118", "country": "US", "domain_rank": 408, "title": "BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-02-07T14:08:00.000+02:00", "replies_count": 0, "uuid": "0a8d5c9660e2b966d167772be40cdd56eb028264"}, "author": "", "url": "https://www.reuters.com/article/brief-akcea-completes-enrollment-in-phas/brief-akcea-completes-enrollment-in-phase-2b-study-of-akcea-apo-lrx-idUSFWN1PX118", "ord_in_thread": 0, "title": "BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "akc", "sentiment": "negative"}, {"name": "akcea therapeutics inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "February 7, 2018 / 12:09 PM / in 9 minutes BRIEF-Akcea Completes Enrollment In Phase 2B Study Of Akcea-Apo(A)-LRx Reuters Staff 1 Min Read \nFeb 7 (Reuters) - Akcea Therapeutics Inc: \n* AKCEA COMPLETES ENROLLMENT IN PHASE 2B STUDY OF AKCEA-APO(A)-LRX Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-02-07T14:08:00.000+02:00", "crawled": "2018-02-07T14:21:20.003+02:00", "highlightTitle": ""}